Issue link: https://www.e-digitaleditions.com/i/1475629
Technical articles discuss computational fluid dynamics (CFD) capabilities and the processes and considerations required to create a trusted, useful, predictive simulation to support the product development process. The issue also presents the second part of a two-part series on formulation development of adhesive mixtures for inhalation. The Cross-industry organizations column provides an update from The Aerosol Society. The Back page article describes the AAFA HEAL Innovation program. 2 August 2022 Inhalation Inhalation (ISSN 1937-0717 print; ISSN 1940-414X online) is published seven times per year in January, February, April, June, August, October and December by Whipsnade and Loophole, LLC, P.O. Box 27092, Minneapolis, MN 55427 US. w w w . i n h a l a t i o n m a g . c o m August 2022 Volume 16 Number 4 particle characterization 10 Computational fluid dynamics (CFD) for pharmaceutical aerosol device development: Simulations and processes to facilitate success Joseph Camm 20 Issue focus: Particle characterization particle manufacturing 30 Special section: Particle manufacturing additional features 6 Cross-industry organizations: The Aerosol Society: Recent activities and a preview of DDL2022 22 Formulation development of adhesive mixtures for inhalation—A multi-factorial optimization challenge: Part 2 Kyrre Thalberg 35 Back page: AAFA launches HEAL Innovation to continue addressing asthma disparities identified in 2020 report departments 8 Industry news 8 Respiratory medicine news 32 Calendar 33 Literature review The cover photo shows the PreciseInhale ® aerosol generator used for in vitro and in vivo pharmacokinetic (PK) studies, with a dry powder inhaler (DPI) attached. Courtesy of Inhalation Sciences, Hälsovägen 7, SE-141 57 Huddinge, Sweden, Tel: +46 705 625 195, contact@inhalation.se, www.inhalation.se